These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23107783)

  • 1. Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine.
    He XS; Sasaki S; Baer J; Khurana S; Golding H; Treanor JJ; Topham DJ; Sangster MY; Jin H; Dekker CL; Subbarao K; Greenberg HB
    J Infect Dis; 2013 Jan; 207(2):288-96. PubMed ID: 23107783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.
    He XS; Holmes TH; Sanyal M; Albrecht RA; García-Sastre A; Dekker CL; Davis MM; Greenberg HB
    J Infect Dis; 2015 Apr; 211(7):1051-9. PubMed ID: 25336731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
    Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
    Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination.
    Sangster MY; Baer J; Santiago FW; Fitzgerald T; Ilyushina NA; Sundararajan A; Henn AD; Krammer F; Yang H; Luke CJ; Zand MS; Wright PF; Treanor JJ; Topham DJ; Subbarao K
    Clin Vaccine Immunol; 2013 Jun; 20(6):867-76. PubMed ID: 23576673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
    Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
    Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
    Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials.
    van der Most RG; Clément F; Willekens J; Dewé W; Walravens K; Vaughn DW; Leroux-Roels G
    Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28446441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans.
    Miller MS; Tsibane T; Krammer F; Hai R; Rahmat S; Basler CF; Palese P
    J Infect Dis; 2013 Jan; 207(1):98-105. PubMed ID: 23087428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans.
    Nachbagauer R; Wohlbold TJ; Hirsh A; Hai R; Sjursen H; Palese P; Cox RJ; Krammer F
    J Virol; 2014 Nov; 88(22):13260-8. PubMed ID: 25210189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
    Haveri A; Ikonen N; Kantele A; Anttila VJ; Ruotsalainen E; Savolainen-Kopra C; Julkunen I
    Vaccine; 2019 May; 37(20):2731-2740. PubMed ID: 30954308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
    Petrie JG; Parkhouse K; Ohmit SE; Malosh RE; Monto AS; Hensley SE
    J Infect Dis; 2016 Dec; 214(12):1947-1951. PubMed ID: 27923954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.
    Nayak JL; Fitzgerald TF; Richards KA; Yang H; Treanor JJ; Sant AJ
    J Infect Dis; 2013 Jan; 207(2):297-305. PubMed ID: 23148285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a monovalent pandemic influenza A H1N1 virus vaccine with or without prior seasonal influenza vaccine administration.
    Igari H; Watanabe A; Segawa S; Suzuki A; Watanabe M; Sakurai T; Watanabe M; Tatsumi K; Nakayama M; Suzuki K; Sato T
    Clin Vaccine Immunol; 2012 Oct; 19(10):1690-2. PubMed ID: 22855394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines.
    Sasaki S; Holmes TH; Albrecht RA; García-Sastre A; Dekker CL; He XS; Greenberg HB
    J Infect Dis; 2014 Sep; 210(6):865-74. PubMed ID: 24676204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
    Ott U; Sauerbrei A; Lange J; Schäfler A; Walther M; Wolf G; Wutzler P; Zell R; Krumbholz A
    Med Microbiol Immunol; 2012 Aug; 201(3):297-302. PubMed ID: 22350187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.